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BACKGROUND:  Peritoneal  carcinomatosis  of gastric  origin  is  a frequent  event  with  poor  survival.  A
new  promising  approach  is  the  association  of  the Cytoreductive  Surgery  (CRS)  with  the  Hyperthermic
Intraperitoneal  Chemotherapy  (HIPEC),  which  yet  is characterized  by  high  morbidity  and  mortality.
We  report,  to  our  knowledge,  the  ﬁrst  case  of Wernicke  Encephalopathy  (WE)  complicating  CRS  plus
HIPEC.  WE,  caused  by  a  deﬁciency  of thiamine,  is characterized  by  ataxia,  ocular  motor  cranial  neu-
ropathies  and  changes  in  consciousness.
METHODS:  A  patient  affected  by gastric  cancer  with  peritoneal  seeding,  submitted  to  CRS  plus HIPEC,
in  4th post-operative  day  had  manifested  the  appearance  of ﬂapping  tremors,  with  positive  manoeu-
vre  of  Mingazzini,  impaired  vision  and  mental  confusion.  The  brain  Magnetic  Resonance  Imaging  (MRI)IPEC
omplications
conﬁrmed  the  clinical  suspicion  of  WE. Even  though  the  appropriate  therapy  was promptly  applied,  the
patient  died  in  10th  post-operative  day.
CONCLUSION:  WE  is  an  uncommon  neurological  disorder.  Only  16%  of  these  patients  inadequately  treated
recover  fully,  with a  mortality  rate  of 10–20%.  We  consider  useful  to report  this  case,  because  it is the
ﬁrst  time  that  WE  is correlated  to  CRS  plus  HIPEC.
©  2015  The  Authors.  Published  by Elsevier  Ltd.  on behalf  of  Surgical  Associates  Ltd.  This  is  an  open
access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).. Introduction
Peritoneal carcinomatosis (PC) of gastric origin is a frequent
vent even in the early phase of the disease, but especially in
dvanced cases. PC, once established, is associated with poor sur-
ival as shown by many phase III trials that reported median
urvival ranging from 1 to 13.8 months [1] and no survivors at ﬁve
ears [2]. Investigators worldwide have continued to study poten-
ial treatment options for patients with gastric cancer with limited
arcinomatosis, encouraged by the results, obtained in a small but
eaningful number patients with carcinomatosis of appendicealnd colorectal origin [3–5] with the association of Cytoreductive
urgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy
HIPEC). Despite CRS plus HIPEC are burdened by a high morbid-
Abbreviations: WE,  Wernicke Encephalopathy; PC, peritoneal carcinomato-
is; MRI, magnetic resonance imaging; HIPEC, Hyperthermic Intraperitoneal
hemotherapy; CRS, Cytoreductive Surgery; CDDP, cisplatin; ICU, Intensive Care
nit; BMI, body mass index; p.o.-day, pos-operative day.
∗ Corresponding author. Fax: +39 0902212633.
E-mail address: franz.ﬂeres@gmail.com (F. Fleres).
ttp://dx.doi.org/10.1016/j.ijscr.2015.09.012
210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Assoc
reativecommons.org/licenses/by-nc-nd/4.0/).ity [6] WE  has never been recognized among complications. WE,
an uncommon neurological disorder described for the ﬁrst time
by Carl Wernicke [7] is caused by a deﬁciency of thiamine and is
characterized by a classical triad of symptoms, consisting of ataxia,
ocular motor cranial neuropathies and changes in consciousness
[8,9]. We report, to our knowledge, the ﬁrst case of WE  complicat-
ing CRS plus HIPEC used as treatment of peritoneal carcinomatosis
of gastric origin.
2. Case history
A 60 year-old man  was referred to our institution for a poorly dif-
ferentiated adenocarcinoma of the gastric body. He was a moderate
drinker (about 0.5–1 glass of wine/day) and non-smoker. His BMI
was 23.5. His medical history was not characterized by nothing rel-
evant. Preoperative oncological staging revealed the involvement
of the gastric serosal and the presence of a cleavage plane with
the pancreas. The patient was submitted to a D2 subtotal gastrec-
tomy according to Roux. A lesion white-yellowish, found on the
left diaphragmatic peritoneum, was removed and its intraoperative
histological examination demonstrated the metastatic origin, while
iates Ltd. This is an open access article under the CC BY-NC-ND license (http://
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oFig. 1. Left diaphragm after peritonectomy.
he cytological exam of peritoneal lavage was negative. There-
ore, the patient was submitted also to subtotal left diaphragmatic
eritonectomy (Fig. 1) and HIPEC with closed abdomen technique
ith 191 mg  of cisplatin (CDDP) plus 25 mg  of Mitomycin C for
0 min. Histological examination of the stomach showed an inva-
ive malignant proliferation, extensively ulcerated, inﬁltrated the
astric wall up to the tunica serosa, characterized by irregular
lands with hyperchromatic nuclei and non-cohesive individual
ells inﬁltrating the stroma. Morphological features were consis-
ent with poorly-differentiated gastric adenocarcinoma (Fig. 2).
he pathological examination of the twenty removed lymph nodes
emonstrated that two perigastric nodes were metastatic. The
eﬁnitive exam conﬁrmed the neoplastic nature of the peritoneal
odule (Fig. 3). The post-operative pathological staging was there-
ore pT4aN1M1.
After 24 h in Intensive Care Unit (ICU), the patient was  trans-
erred in surgical department. In 4th post-operative (p.o.)-day, in
bsence of other complications, occurred the appearance of ﬂap-
ing tremors, with positive manoeuvre of Mingazzini, impaired
ision and mental confusion. The patient was submitted to a brain
RI, that showed, in T2-weighted scans, a hyperintense area in
he periaqueductal gray matter; after intravenous (i.v.) adminis-
ration of Gadolinium was demonstrated the highlight involvement
f the mammillary bodies. Therefore the imaging, also at the light
Fig. 2. Histological examination of the gastric lesion.PEN  ACCESS
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of clinical picture, allowed to perform the diagnosis of WE.  The
patient was transferred again to the ICU and was  submitted to the
treatment with thiamine 100 mg  daily i.v. Nevertheless, in 10th
p.o.-day, he died.
3. Discussion
In literature, CRS plus HIPEC are correlated with morbidity and
mortality rates that ranges from 12 to 57% and from 0.9 to 11%
[7] respectively. Comparing the various data of the major records
that have calculated the incidence of grades III–IV events, the prin-
cipal complications are anastomotic leaks, digestive perforations,
biliary ﬁstula, pancreatic ﬁstula, ileus/gastric stasis, intraperitoneal
abscesses, pancreatitis, nausea/vomiting, small bowel obstruction,
urinary disturbance, bleeding, respiratory distress [7]. In the lit-
erature we  did not ﬁnd any case of WE  complicating CRS plus
HIPEC. WE  is an uncommon neurological disorder described for
the ﬁrst time in 1881 by Carl Wernicke, characterized by a clas-
sical triad of symptoms consisting of ataxia, ocular motor cranial
neuropathies and changes in consciousness [8]. A deﬁciency of
thiamine is responsible for the complex symptoms characteriz-
ing this syndrome. In fact, WE  occurs primarily in the alcoholics
while, in the 23% of cases, it can be associated with some non-
alcoholic conditions (prolonged intravenous feeding, hyperemesis
gravidarum, anorexia, refeeding after starvation, thyrotoxicosis,
regional enteritis, malabsorption syndromes, hemodialysis, peri-
toneal dialysis, uremia, HIV, malignancy, restoration stage of severe
acute pancreatitis, and gastroplasty with postoperative vomit-
ing) [8]. Animal studies showed that also tumor growth might
be related to the depletion of tissutal thiamine stores, appar-
ently because of increased thiamine utilization, and some clinical
reports have underlined that secondary thiamine deﬁciency can
be associated with chemotherapy [9]. All these conditions lead
to decreased activation of thiamine pyrophosphate from thi-
amine, that serves as a cofactor for three critical enzymes in
the intermediate carbohydrate metabolism: transketolase, ketog-
lutarate dehydrogenase and pyruvate dehydrogenase complex
[10].
Actually a certain diagnosis is performed only in 5–14% of cases
[11]. The diagnosis criteria require 2 of the following 4 signs: dietary
deﬁciencies, oculomotor abnormalities, cerebellar dysfunction, and
either an altered mental state or mild memory impairment, even
if only about 16% of patients had the classic clinical triad, and 19%
had no clinical signs. The gold standard in imaging is MRI  with a
sensitivity of 53% and a speciﬁcity of 93% [11]. Actually only 16% of
patients with WE  inadequately treated recover fully, with a mor-
Fig. 3. Microscopic appearance of metastatic deposits in peritoneal tissue.
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Fig. 4. The graph shows cisplatin (CDDP) serum level trends with error bars as standard deviation. On the right are also reported the values of standard deviation in order.
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ality rate of 10–20% [8]. The treatment consists in the immediate
dministration of intravenous (i.v.) thiamine. The clinical response
fter administering thiamine is usually striking and rapid enough to
e virtually diagnostic. Hence, the prognosis of WE  depends on the
tage of disease and prompt institution of therapy with thiamine
10].
In our clinical case the diagnosis of WE  was performed on
he basis of the typical clinical triad, characterized by positive
ingazzini manoeuvre, impaired vision and mental confusion. MRI
ocumented in T2-weighted scans, a hyperintense area in the peri-
queductal gray matter and, after i.v. administration of Gadolinium,
he highlight involvement of the mammillary bodies. These instru-
ental ﬁndings permitted to conﬁrm the clinical diagnosis of
E,  for which the patients was transferred in ICU. Notwithstand-
ng the prompt therapies, the patient, in 10th p.o.-day, died, in
ccordance with the data reported in other manuscripts [12],
hich show that a number of patients can die even if properly
reated.
As our patient was not heavy drinker, nor malnourished, we
elieve, as reported in literature [9], that the onset of the WE  can be
elated to chemotherapy and to primary tumor, that, by increasing
etabolism, had led to the depletion of thiamine.
The peculiarity of our case is to be identiﬁed in the intraperi-
oneal administration route of chemotherapy, which should reduce
he systemic effects.
We  have already shown [13], that the serum level of cis-
latin (Fig. 4). although intraperitoneally administered, peaks
6.52 ± 1.61 g/L) during perfusion, remains high (1.79 ± 0.76 g/L)
p to the 4th p.o.-day, and only in the 7th p.o.-day, returns to
he basal values (0.92 ± 0.1 g/L), whereby also the HIPEC may  be
esponsible for systemic complications.e respectively at 0 time, in the middle of perfusion and at the end of perfusion.
In light of this case report, we  believe useful to include, among
potential complications of CRS plus HIPEC, also WE.
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